A look at 2024 acquisition market shiftsFebruary 4, 2024These shifts include everything, from pricing dynamics, deal structures, seller profiles, the likelihood of deal closure, and more.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Elanco closes $444M purchase of biopharma co.August 31, 2021Elanco Animal Health has expanded its reach into the veterinary dermatology market with the $444-million acquisition of biopharma company, Kindred Biosciences.
Elanco acquires biopharma co. in $440M dealJune 16, 2021A major player in the global animal health industry has expanded its reach into the veterinary dermatology market with the purchase of a biopharmaceutical company.
100-year-old distributor purchased by large subsidiaryMay 7, 2021Nebraska-based multiregional veterinary distributor Miller Vet has been purchased by Patterson Veterinary Supply, a subsidiary of Patterson Companies.
$7.6-billion Elanco deal gets FTC green lightJuly 15, 2020Elanco Animal Health has received unanimous approval for its $7.6-billion acquisition of Bayer’s animal health division.
Pharma manufacturer expands with purchase of facility in FranceApril 3, 2020A U.S.-based manufacturer of canine and equine joint health pharmaceuticals has expanded its capabilities with the purchase of a European active pharmaceutical ingredient (API) manufacturing plant.
Service provider scoops up hospital networkMarch 16, 2020Destination Pet is set to purchase veterinary hospital network, VitalPet, which will add 24 veterinary hospitals to its network.
Diagnostics growth drives Zoetis' latest acquisitionFebruary 14, 2020Four months after venturing into the world of reference laboratory services, Zoetis has bolstered its presence within the space through the acquisition of Ethos Diagnostic Science.
Covetrus to sell diagnostics subsidiary to Heska for $125 millionJanuary 16, 2020Covetrus is divesting itself of its Scil Animal Care business to Heska Corp. in an all-cash deal worth US$125 million. Subject to customary closing conditions, the transaction is expected to close in the next 60 to 90 days. Headquartered in Germany, Scil is a veterinary diagnostics company that distributes in 24 countries. The agreement also includes a commercial relationship between Covetrus and Heska tied to ongoing logistics support for the latter's family of diagnostic products, as well as connectivity between the Covetrus Global Technology Solutions practice information management software systems (PIMS) and Heska's laboratory and imaging solutions. Covetrus says the net cash proceeds from the sale will go toward paying down debt. In addition, the proceeds may also be used for other general corporate purposes. "While we are still in the early stages of executing on our strategy, this transaction is an important initial step in that process," says Ben Wolin, Covetrus' acting president and chief executive officer. In related company news, Covetrus also announced it was combining its Spain and Portugal businesses with Distrivet, a provider of veterinary products and services in Spain. As a result, Covetrus will own 50.01 percent of Distrivet. The deal is expected to close …
MetLife acquisition reflects growing pet insurance marketDecember 5, 2019MetLife Inc., a financial service company operating in more than 40 markets worldwide, has acquired Jeffersonville, Ind.,-based pet health insurance administrator, PetFirst Healthcare.
